{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-106322","form_type":"8-K","ticker":"PTPI","cik":"0001815903","company_name":"Petros Pharmaceuticals, Inc.","filed_at":"2024-10-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.788000+00:00","generated_at":"2026-05-30T20:37:49.950370+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Two directors resign from Petros Pharmaceuticals board without disagreement","bullets":["John Shulman resigned as director effective Oct 1, 2024; no disagreement cited.","Greg Bradley resigned as director effective Oct 2, 2024; no disagreement cited.","No replacements announced; remaining board composition unclear."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-106322","json":"https://secwatch.observer/filing/0001104659-24-106322.json","markdown":"https://secwatch.observer/filing/0001104659-24-106322.md","text":"https://secwatch.observer/filing/0001104659-24-106322.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815903/000110465924106322/0001104659-24-106322-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815903/000110465924106322/tm2425618d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T20:37:49.950370+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f5825595c","claim":"John Shulman resigned as director at Petros Pharmaceuticals, Inc..","evidence_excerpt":"On October 1, 2024, John Shulman, who served as a member of the board of directors (the “Board”) of Petros Pharmaceuticals, Inc. (the “Company”), tendered his resignation from his role as director of the Company, effective as of October 1, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465924106322/0001104659-24-106322-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"23ab55b1c6","claim":"Greg Bradley resigned as director at Petros Pharmaceuticals, Inc..","evidence_excerpt":"On October 2, 2024, Greg Bradley, who served as a member of the Board tendered his resignation from his role as director of the Company, effective as of October 2, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815903/000110465924106322/0001104659-24-106322-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}